Technical Specialist
Chuanwen Zhou, Ph.D., focuses on patent drafting, prosecution, and client counseling within the biotechnology and chemical sectors. He brings extensive experience in patent due diligence and freedom-to-operate (FTO) analyses for biopharmaceutical investment projects, including technologies such as antibodies, nucleic acid-based drugs, small molecule compounds, antibody-drug conjugates, peptides, fusion proteins, cell therapies, and vaccines.
Chuanwen provides clients with strategic counseling on intellectual property (IP) matters. His practice encompasses patentability assessments and portfolio management, as well as IP analysis across a broad range of biotechnological and pharmaceutical innovations. He is a Chinese-qualified patent agent and previously practiced patent law at a Chinese law firm.
Articles
Comparing Patent Infringement Litigation: China vs. United States - Pleading Standards and Discovery in Patent Cases Comparing Patent Infringement Litigation: China vs. United States - Pleading Standards and Discovery in Patent Cases
November 25, 2025
Articles
Understanding Chinese Customs IP Enforcement for Non-Chinese Stakeholders: An Overview of China’s Customs Intellectual Property Protection Practices Understanding Chinese Customs IP Enforcement for Non-Chinese Stakeholders: An Overview of China’s Customs Intellectual Property Protection Practices
October 28, 2025
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.